Key points are not available for this paper at this time.
Background This study aimed toinvestigate the association between clinical and laboratory parameters andresponse to therapy with sodium-glucose cotransporter 2 inhibitors (SGLT2i) inpatients with type 2 diabetes mellitus (T2D).
Pitsiava et al. (Thu,) studied this question.